Create Free Account

By creating account you will get access to hot stocks & personalised emails

EZZ Life Science Holdings Ltd

Healthcare AU EZZ

0.82AUD
-0.01(1.20%)

Last update at 2024-05-08T04:15:00Z

Day Range

0.820.83
LowHigh

52 Week Range

0.430.92
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 4.90M 1.78M 2.74M 2.15M 1.18M
Minority interest - - - - -
Net income 3.63M 1.31M 2.03M 1.59M 0.82M
Selling general administrative 1.15M 0.90M 0.68M 0.30M 0.90M
Selling and marketing expenses 20.56M 2.97M 7.84M 1.55M 1.97M
Gross profit 27.20M 7.51M 12.46M 3.56M 4.36M
Reconciled depreciation 0.18M 0.12M 0.13M - -
Ebit 4.62M 1.78M 2.75M 1.48M 1.18M
Ebitda 4.80M 1.90M 2.87M 1.63M 1.18M
Depreciation and amortization 0.18M 0.12M 0.13M 0.15M 0.00340M
Non operating income net other - - - - -
Operating income 4.62M 1.78M 2.75M 1.48M 1.18M
Other operating expenses 32.53M 13.38M 19.71M 15.84M 10.01M
Interest expense 0.01M 0.00444M 0.01M 0.00591M 0.00000M
Tax provision 1.27M 0.47M 0.71M 0.56M 0.35M
Interest income 0.24M 0.00037M 0.01M 0.00591M -
Net interest income 0.03M -0.00407M -0.01075M - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.27M 0.47M 0.71M 0.56M 0.35M
Total revenue 37.14M 15.02M 22.29M 17.32M 11.19M
Total operating expenses 22.59M 5.87M 9.89M 2.08M 3.18M
Cost of revenue 9.94M 7.51M 9.83M 13.75M 6.83M
Total other income expense net 0.29M 0.14M 0.17M 0.67M -0.00000M
Discontinued operations - - - - -
Net income from continuing ops 3.63M 1.31M 2.03M - -
Net income applicable to common shares 3.63M 1.31M 2.03M 1.59M 0.82M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 17.64M 14.27M 12.04M 11.63M 2.91M
Intangible assets 0.02M 0.02M 0.01M 0.00100M -
Earning assets - - - - -
Other current assets 0.94M 0.90M 0.42M 0.34M -
Total liab 3.06M 2.88M 1.93M 3.78M 2.09M
Total stockholder equity 14.58M 11.39M 10.11M 7.85M 0.82M
Deferred long term liab - - - - -
Other current liab 0.36M 0.32M 0.26M 0.54M 0.58M
Common stock 6.00M 5.82M 5.67M 5.62M 0.00010M
Capital stock 6.00M 5.82M 5.67M 5.62M -
Retained earnings 8.58M 5.56M 4.44M 2.23M 0.82M
Other liab - 0.06M 0.00133M - -
Good will - - - - -
Other assets 0.01M 0.13M 0.16M 0.00417M 0.00114M
Cash 13.83M 10.46M 8.85M 8.41M 0.41M
Cash and equivalents - - - - -
Total current liabilities 2.93M 2.82M 1.93M 3.78M 2.09M
Current deferred revenue - - - - -
Net debt - -10.36027M -8.77463M -8.37500M -
Short term debt 0.00000M 0.10M 0.08M 0.03M 0.00000M
Short long term debt - - - - -
Short long term debt total - 0.10M 0.08M 0.03M -
Other stockholder equity 0.00081M - - - -
Property plant equipment 0.60M 0.15M 0.13M 0.10M 0.09M
Total current assets 17.01M 13.97M 11.73M 11.32M 2.82M
Long term investments - - - - -
Net tangible assets 14.56M 11.37M 10.10M 2.41M 0.82M
Short term investments - - - - -
Net receivables 1.39M 2.29M 2.19M 2.54M 2.41M
Long term debt - - - - -
Inventory 0.85M 0.31M 0.27M 0.03M -
Accounts payable 2.14M 2.39M 1.59M 3.20M 1.36M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.63M 0.29M 0.30M 0.31M -
Capital lease obligations 0.48M 0.10M 0.08M 0.03M -
Long term debt total 0.12M 0.00000M 0.00000M 0.00000M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.10179M -0.01318M -0.01612M - -
Change to liabilities -0.16386M 0.88M -1.71869M 1.56M 1.64M
Total cashflows from investing activities -0.10179M -0.01318M -0.01612M -0.09120M -0.00254M
Net borrowings -0.16132M -0.10419M -0.10726M -0.12225M -0.12225M
Total cash from financing activities -0.76172M -0.27736M 5.44M -0.12225M -0.12225M
Change to operating activities -0.01565M -0.47738M -0.06108M 0.01M 0.00381M
Net income 3.63M 1.31M 2.03M 1.59M 0.82M
Change in cash 3.37M 1.61M 5.68M 2.76M 0.41M
Begin period cash flow 10.46M 8.85M 3.17M 0.41M 0.00010M
End period cash flow 13.83M 10.46M 8.85M 3.17M 0.41M
Total cash from operating activities 4.01M 1.90M 0.25M 2.97M 0.42M
Issuance of capital stock - - 6.00M - -
Depreciation 0.18M 0.12M 0.13M 0.15M 0.00340M
Other cashflows from investing activities - - - - -
Dividends paid -0.60039M 0.17M 0.11M 0.17M 0.17M
Change to inventory -0.53452M -0.04079M -0.23880M -0.03281M -0.03281M
Change to account receivables 0.91M -0.10503M 0.35M -0.46497M -2.41044M
Sale purchase of stock - 0.00000M -0.44984M - -
Other cashflows from financing activities -0.16132M -0.10419M 0.11M -0.12225M -0.00254M
Change to netincome -0.03927M 0.16M 0.00149M 0.00149M 0.00149M
Capital expenditures 0.10M 0.01M 0.02M 0.09M 0.00254M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.24M 0.31M -1.90409M 1.24M -0.41089M
Stock based compensation 0.18M 0.16M - - -
Other non cash items 0.17M -0.23994M 0.00150M -0.76773M 0.78M
Free cash flow 3.91M -0.01318M 0.24M 2.88M 0.41M

Fundamentals

  • Previous Close 0.83
  • Market Cap36.64M
  • Volume45575
  • P/E Ratio10.00
  • Dividend Yield3.04%
  • EBITDA4.42M
  • Revenue TTM43.73M
  • Revenue Per Share TTM1.02
  • Gross Profit TTM 28.55M
  • Diluted EPS TTM0.08

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EZZ
EZZ Life Science Holdings Ltd		 -0.01 1.20% 0.82 10.00 - 0.82 2.35 0.54 4.73
CSL
CSL Ltd		 -0.13 0.05% 279.43 35.44 31.35 9.60 5.16 10.91 34.93
TLX
Telix Pharmaceuticals Ltd		 0.17 1.14% 15.14 748.00 21.01 8.47 28.69 8.21 177.65
NEU
Neuren Pharmaceuticals Ltd		 -0.33 1.63% 19.92 15.98 38.46 11.63 13.15 10.65 12.39
MSB
Mesoblast Ltd		 -0.055 4.68% 1.12 - 769.23 116.88 1.12 126.11 -19.3368

Reports Covered

Stock Research & News

View All

Profile

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned Products. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers; and research and development, and sale of genomics and precision nutrition research products under the EZZ brand. The company also offers its products online. EZZ Life Science Holdings Limited was incorporated in 2015 and is based in Silverwater, Australia.

EZZ Life Science Holdings Ltd

104 Derby Street, Silverwater, NSW, Australia, 2128

Key Executives

Name Title Year Born
Mr. Mark Qin Co-founder, COO, Interim CEO & Exec. Director NA
Anthony Guarna Chief Financial Officer NA
Ms. Natalie Climo L.L.B. Company Sec. NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA
Ms. Natalie Climo L.L.B. Company Secretary NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA
Ms. Natalie Climo L.L.B. Company Secretary NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA
Ms. Natalie Climo L.L.B. Company Secretary NA
Mr. Mark Qin Co-founder, COO, CEO & Executive Director NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.